EX-99.1 2 ss1508564_ex9901.htm JOINT FILING AGREEMENT
EXHIBIT 1

JOINT FILING AGREEMENT

The undersigned hereby agree that the Statement on this Schedule 13D, dated June 17, 2016 (the “Schedule 13D”), with respect to the Ordinary Shares of Ascendis Pharma A/S is filed, and all amendments thereto will be filed, on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13D. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13D, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the 17th day of June, 2016.

 
OrbiMed Advisors LLC
  
       
       
 
By:
 /s/ Samuel D. Isaly
  
   
Name:
Samuel D. Isaly
  
   
Title:
Managing Member
  
         
         
 
OrbiMed Capital GP V LLC
  
       
 
By:
OrbiMed Advisors LLC
  
       
       
 
By:
 /s/ Samuel D. Isaly
  
   
Name:
Samuel D. Isaly
  
   
Title:
Managing Member
  
     
     
 
Samuel D. Isaly
  
     
       
 
By:
   /s/ Samuel D. Isaly  
   
Samuel D. Isaly